Skip to content

Category: Biotechnology

Optiscan Imaging (ASX:OIL) reveals InForm(TM) imaging device for pathology

By API User

Highlights: • Optiscan reveals InForm™, its next generation microscopic medical imaging device specifically designed for pathology workflows. • InForm™ expands Optiscan’s product portfolio into the pathology market, marking a pivotal milestone in advancing the Company’s strategic objectives. • InForm™ can be used in a variety of pathology settings, most notably in laboratory medicine, pathology practice, point-of-care and … Continued

Stronger, safer, smarter: pioneering Zinc-based dissolvable implants for better bone repair

By API User

Monash research could transform how broken bones are treated, with the development of a special zinc-based dissolvable material that could replace the metal plates and screws typically used to hold fractured bones together.  Surgeons routinely use stainless steel or titanium, which stay in the body forever, can cause discomfort and may require follow-up surgeries. A … Continued

BTC announces CFO and Company Secretary appointment

By API User

Melbourne, Australia: BTC Health (ASX: BTC) (BTC or the Company) is pleased to announce the appointment of Salesh Balak as Chief Financial Officer and Company Secretary, effective 17 March 2025. This appointment reflects the underlying expansion of the BTC business, and the appointment of Josh Kahanovitz, current Head of Finance, into the role of Chief Operating Officer from … Continued

BTC expands distribution partnership with Arna Pharma

By API User

•  License and distribution agreement for Bronchitol and Aridol converted from an initial 10- year term to an indefinite license •  BTC to earn royalties from sales of Bronchitol and Aridol in Singapore and Malaysia •  BTC granted first right of refusal to Arna Pharma’s new product pipeline Melbourne, Australia: BTC Health (ASX: BTC) (BTC or the … Continued

Leading Chicago Pediatric Cente, North Shore Pediatric Therapy, Joins BlinkLab’s US Autism Diagnostic Registrational Study

By API User

10 February 2025 – Sydney, Australia | BlinkLab Limited (ASX:BB1) (“BlinkLab” or “the Company”), an innovative digital healthcare company utilising AI-powered smartphone technology as part of a neurodevelopmental diagnostic approach, is pleased to announce that North Shore Pediatric Therapy (NSPT) has joined its US registrational study as the second clinical site. NSPT, a well-known provider … Continued

OncoSil Medical (ASX:OSL) Investor Webinar Invitation

By API User

Sydney, Australia – 7 February 2025: Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) will host an investor webinar on Tuesday 11 February 2025. The webinar will be presented by OncoSil’s Chief Executive Officer & Managing Director, Nigel Lange, and will be followed by a short Q&A session. In his webinar presentation, Mr Lange … Continued

AdAlta (ASX:1AD) investor webinar invitation: “East to West” cellular immunotherapy strategy

By API User

The webinar will be presented by AdAlta’s Chief Executive Officer & Managing Director, Dr Tim Oldham, and will be followed by a short Q&A session In his webinar presentation, Dr Oldham will discuss the results of AdAlta’s strategic review and portfolio prioritization announced separately today, including: • What drives AdAlta’s “East to West” cellular immunotherapy strategy• … Continued

BlinkLab Limited (ASX:BB1) Initiates First US-Based Clinical Site for Autism Diagnostic Registrational Trial

By API User

5 February 2025 – Sydney, Australia | BlinkLab Limited (ASX: BB1) (“BlinkLab” or “the Company”), an innovative digital healthcare company leveraging AI-powered smartphone technology to transform autism and ADHD diagnostics, is pleased to announce the initiation of its first US-based clinical site for the autism diagnostic registrational trial. The PriMED Clinical Research LLC (“PriMED”) facility … Continued

Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment

By API User

With Northway Biotech’s expertise in biologics manufacturing, Mallia aims to enter the multi-billion-dollar alopecia market by delivering a safe and effective topical sCD83 treatment designed to stimulate hair follicle formation and promote sustained hair growth. ERLANGEN, GERMANY AND VILNIUS, LITHUANIA / ACCESS Newswire / February 4, 2025 / Mallia Therapeutics ("Mallia"), a biopharmaceutical company developing … Continued

120 German Hospitals legally entitled to negotiate fee for OncoSil

By API User

Sydney, Australia – 04 February 2025: Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) (“OncoSil” or “the Company”) is pleased to announce that German Institute for the Hospital Remuneration System (InEK) has authorised 120 German hospitals to negotiate funding for the OncoSil™ device classification under the innovation funding (NUB) program with the statutory health insurance (SHI) … Continued